BRUSSELS / RankWire.AI / – Public health institute Sciensano has published Belgium’s first comprehensive measurement of obesity-related mortality, attributing 9,509 deaths in 2022—or 8.2 percent of the country’s total deaths—to an excessively high body mass index. Equating to more than one death every hour, weight-related health complications accounted for over 150,000 lost years of life nationwide, establishing a new quantitative baseline for Belgian health policy planners.
The comprehensive epidemiological investigation examined underlying causes of death to determine how elevated body mass index contributes to chronic health conditions. Research findings identified cardiovascular complications as the primary contributor to mortality, with coronary heart diseases accounting for 2,009 deaths. Neurodegenerative disorders represented the second largest category, as Alzheimer disease and other forms of dementia were linked to 1,652 deaths. Additionally, cerebrovascular diseases were cited in 1,171 deaths, alongside significant contributions from chronic kidney disease and various digestive cancers.
Demographic breakdowns within the dataset demonstrate that mortality risks associated with elevated weight expand significantly alongside advancing age. Individuals aged 65 and older experienced the highest concentration of health complications related to excessive body weight. Gender analysis revealed that male mortality rates exceeded female rates across most age brackets. However, among citizens aged 85 and older, women recorded higher total mortality figures, a trend epidemiologists attribute to longer average life expectancy among female demographics.
Demographic Data Shows Higher Risk Among Citizens Aged Over Sixty Five
Geographical evaluation across the federal territory highlighted pronounced regional disparities in mortality rates tied to excessive weight. The southern region of Wallonia recorded the highest mortality level, registering 95.21 deaths per 100,000 residents. The Brussels-Capital Region followed with an age-standardized rate of 85 deaths per 100,000 residents. Flanders recorded the lowest relative impact, logging 73.60 deaths per 100,000 people. Public health analysts note these regional variations reflect underlying socioeconomic differences, dietary patterns, and healthcare access profiles across the Belgian federation.
The publication of this data coincides with policy assessments carried out under the guidance of the Federal Public Service Health, which oversees national health strategies. Public health officials are utilizing the findings to assess the long-term economic burden placed on the healthcare system by chronic non-communicable diseases. The comparative risk assessment methodology employed by researchers involved calculating the population attributable fraction for each disease, establishing baseline estimates to guide future preventative health interventions.
Cerebrovascular Complications Represent Third Largest Cause of Death
At the European level, health institutions such as the European Centre for Disease Prevention and Control track similar metabolic risk factors to coordinate regional policy frameworks. The Belgian report aligns with wider European Union health monitoring goals aimed at reducing premature mortality from non-communicable conditions. International health guidelines maintained by the World Health Organization continue to recommend integrated multi-sectoral strategies to curb metabolic risk factors, emphasizing public education, nutritional labeling, and early clinical management.
The findings establish an empirical foundation for health authorities seeking to lower the incidence of high body mass index across Western Europe. By quantifying both mortality totals and years of life lost, public health planners can prioritize resources toward screening, intervention programs, and lifestyle management initiatives. As regional administrations analyze the data, federal health frameworks are expected to focus on early preventative care to reduce chronic disease prevalence nationwide.